UBS Group’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
Other funds holding RMTI
UBS Group's RMTI Position: Q3 2026 in Review
UBS Group increased its Rockwell Medical (RMTI) stake by 43% in Q3 2026, buying an estimated $22K and bringing the position to 10,009 shares worth $85.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7254.
UBS Group first reported a position in RMTI in Q4 2014 and has held it in 48 quarters since. The position peaked at $556K in Q2 2016. 28 funds tracked by Wall St. Rank hold RMTI as of Q3 2026.
- UBS Group held 10,009 shares of Rockwell Medical worth $85.5K as of Q3 2026.
- UBS Group bought 3,008 Rockwell Medical shares in Q3 2026, an estimated $22K.
- Rockwell Medical made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #7254 holding.
- UBS Group first reported a position in Rockwell Medical in Q4 2014 and has held it in 48 quarters since.
- UBS Group's Rockwell Medical position peaked at $556K in Q2 2016.
- 28 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.